Real Progress Is Possible On Vaccine Hesitancy
Drew Altman’s Axios column draws on data from the new KFF COVID-19 Vaccine Monitor to assess where the country stands on vaccine hesitancy.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Drew Altman’s Axios column draws on data from the new KFF COVID-19 Vaccine Monitor to assess where the country stands on vaccine hesitancy.
Republicans and Black Americans are More Likely to Be Hesitant but Even Among These Groups Reasons Vary KFF has launched a new COVID-19 Vaccine Monitor to dive deeply into the public’s views about the vaccine and experiences getting it for as long as the pandemic lasts.
This initial survey for the KFF COVID-19 Vaccine Monitor tracks the public’s attitudes and experiences with COVID-19 vaccinations, with a focus on sub-groups of Americans. It explores confidence in vaccines, assesses trust in messengers, and highlights key challenges for vaccination efforts.
This post reviews the latest information on state priorities for their initial COVID-19 vaccine allocations to assess which populations will get the vaccine first.
Approaching the end of 2020, two of the most pressing concerns facing the country are the long-standing issue of racial discrimination and the ongoing coronavirus pandemic. The issues have merged with the pandemic taking a disproportionate health and economic toll on people of color.
This month the Centers for Disease Control and Prevention (CDC) adopted a recommendation that health care workers and long-term care residents should be the first to receive the COVID-19 vaccine once it is authorized or approved by the FDA. A new KFF analysis estimates there are 15.
This analysis provides new national and state-level estimates of the number of health care workers and long-term care residents who are expected to be part of the group first in line to receive the COVID-19 vaccine to gain insight into how this initial priority population varies across states.
Encouraging reports about several COVID-19 vaccine candidates is raising hopes that there will soon be one or more vaccines proven safe and effective, starting a race to produce, distribute, and administer it to essential workers, people at high risk, and the public, including those who may start out with skepticism about the risks posed by…
This brief provides an overview of barriers to vaccination that disproportionately affect people of color and discusses how current national recommendations and state vaccine allocation plans address racial equity.
In this Foreign Affairs article, Josh Michaud and Jen Kates lay out the challenges in vaccinating people in low-income countries around the world and review early plans to ensure safe and effective vaccines are made available and delivered to people across the globe.
© 2025 KFF